
    
      -  Primary objective: Compare IOP-lowering efficacy of morning dosing of Duotrav to
           Xalacom.

        -  Secondary objective: Compare patient dosing preferences for topical prostaglandin
           therapy in terms of convenience and perceived compliance.
    
  